Financials
Income statement
Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 17.0M | 16.1M | 15.5M | 12.8M |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 6.6M | 5.5M | 5.8M | 5.5M |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.7M | 6.5M | 6.1M | 4.8M |
Tax provision | 1.2M | 1.5M | 1.4M | 1.1M |
Net income | 4.5M | 5.0M | 4.7M | 3.7M |
Basic EPS | 0.3 | 0.4 | 0.4 | 0.3 |
Diluted EPS | 0.3 | 0.4 | 0.4 | 0.3 |
Basic average shares | 14.3M | 13.2M | 13.0M | 12.8M |
Diluted average shares | 14.5M | 13.6M | 13.4M | 12.9M |
EBITDA | — | — | — | — |
Net income from continuing op. | 4.5M | — | — | 3.7M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |